QAX
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Hemodialyzer With Expanded Solute Removal Profile
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 876.5862
- Medical specialty
- Gastroenterology, Urology
- Flags
- Life-sustaining
- FDA definition
- A hemodialyzer with expanded solute removal profile is intended for use as part of an artificial kidney system for the treatment of patients with renal failure by performing such therapies as hemodialysis, hemofiltration, and hemodiafiltration. A hemodialyzer with expanded solute removal profile includes modifications to the semipermeable membrane that allows for increased removal of uremic retention solutes compared with standard high-flux hemodialyzers of the high permeability hemodialysis system classification (21 CFR §876.5860), including solutes at the upper end of the middle molecular weight range (0.5 kDa to 60 kDa).
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| ELISIO™-HX (K261399) | Nipro Medical Corporation | 2026-07-28 |
| Theranova Dialyzers, Theranova 400 Dialyzer, Theranova 500 Dialyzer (DEN190042) | Baxter Healthcare Corporation | 2020-08-28 |
Track QAX automatically
Every clearance here is in the API, with alerts when new ones post.